CuraSen Therapeutics, Inc.

ACTIVE

930 Brittan Ave, 加利福尼亚州圣马特奥县, California, United Stateswww.curasen.comHolding11–50 employeesEstablished: 2016-01-01

Clinical Trials

5 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2016

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

40.0%

Trial Status Distribution

Active, not recruiting

30.0%

Completed

20.0%

Not yet recruiting

20.0%

Terminated

10.0%

Withdrawn

20.0%

Clinical Trials

Trials sponsored by this organization (10)

A Study in Subjects With Neurogenic Orthostatic Hypotension

Phase 2

Active, not recruiting

interventional

Sep 202512 participants

A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012)

A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease

Phase 2

Completed

interventional

Apr 202264 participants

A study to investigate if CST-103 and CST-107 has an effect on the brain in patients with progressive disease of the nervous system.

Phase 1

Active, not recruiting

Nov 202140 participants

A Study of CST-2032 in Subjects With Cognitive Impairment

A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders

Phase 2

Completed

interventional

Jun 202141 participants

A Phase 1 Study to Evaluate the Safety, Pharmacokinetic (PK) and Effects of CST-2032 in Healthy Volunteers and Subjects with Mild Cognitive Impairment or Parkinson’s Disease

Phase 1

Terminated

interventional

Sep 202079 participants

A study to look at the effect of CST-103 or CST-139 on blood flow in the brain and on memory.

Phase 1

Active, not recruiting

Sep 202032 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations